BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27272652)

  • 1. Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.
    Cheng XL; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Luo Q; Xiong CM
    Lung; 2016 Aug; 194(4):613-8. PubMed ID: 27272652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
    Tang Y; Yao L; Liu Z; Ma X; Luo Q; Zhao Z; Huang Z; Tu L; Gao L; Jin Q; Ni X; Xiong C
    Pulm Pharmacol Ther; 2017 Apr; 43():26-31. PubMed ID: 28159512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effect of iloprost inhalation and oral sildenafil during acute vasoreactivity test in pulmonary arterial hypertension.
    Sompradeekul S; Wattanasiriphakdee S
    J Med Assoc Thai; 2015 Feb; 98(2):144-9. PubMed ID: 25842794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Gerhardt F; Fiessler E; Olsson KM; Kayser MZ; Kovacs G; Gall H; Ghofrani HA; Badr Eslam R; Lang IM; Benjamin N; Grünig E; Halank M; Lange TJ; Ulrich S; Leuchte H; Held M; Klose H; Ewert R; Wilkens H; Pizarro C; Skowasch D; Wissmüller M; Hellmich M; Olschewski H; Hoeper MM; Rosenkranz S
    Circulation; 2024 May; 149(20):1549-1564. PubMed ID: 38606558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
    J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
    Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
    J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
    Tonelli AR; Alnuaimat H; Mubarak K
    Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
    Hirakawa K; Asano R; Ueda J; Aoki T; Tsuji A; Ogo T
    Int J Cardiol; 2024 Jul; 406():132043. PubMed ID: 38614366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension.
    Xi Q; Liu Z; Zhao Z; Luo Q
    Clin Chim Acta; 2015 Jun; 446():272-6. PubMed ID: 25966828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension.
    Jing ZC; Jiang X; Han ZY; Xu XQ; Wang Y; Wu Y; Lv H; Ma CR; Yang YJ; Pu JL
    Eur Respir J; 2009 Jun; 33(6):1354-60. PubMed ID: 19213781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers.
    Zuo XR; Zhang R; Jiang X; Li XL; Zong F; Xie WP; Wang H; Jing ZC
    Am J Cardiol; 2012 Jun; 109(12):1801-6. PubMed ID: 22459309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension.
    Montani D; Savale L; Natali D; Jaïs X; Herve P; Garcia G; Humbert M; Simonneau G; Sitbon O
    Eur Heart J; 2010 Aug; 31(15):1898-907. PubMed ID: 20543192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.
    Leuchte HH; Baezner C; Baumgartner RA; Muehling O; Neurohr C; Behr J
    Heart; 2015 Jun; 101(12):972-6. PubMed ID: 26015441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
    J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
    Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
    Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and survival of Korean idiopathic pulmonary arterial hypertension patients based on vasoreactivity.
    Ahn JH; Kang BJ; Hong SI; Lee JS; Lee JS; Oh YM; Lee SD
    J Korean Med Sci; 2014 Dec; 29(12):1665-71. PubMed ID: 25469067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Arterial Capacitance Index Is a Strong Predictor for Adverse Outcome in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension.
    Takatsuki S; Nakayama T; Ikehara S; Matsuura H; Ivy DD; Saji T
    J Pediatr; 2017 Jan; 180():75-79.e2. PubMed ID: 27810156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.